Continuous Glucose Monitoring (CGM) Market Share

Statistics for the 2023 & 2024 Continuous Glucose Monitoring (CGM) market share, created by Mordor Intelligence™ Industry Reports. Continuous Glucose Monitoring (CGM) share report includes a market forecast to 2029 and historical overview. Get a sample of this industry share analysis as a free report PDF download.

INSTANT ACCESS

Single User License

$4750

Team License

$5250

Corporate License

$8750

Book before:

Single User License

$4750

Team License

$5250

Corporate License

$8750

Book before:

Market Share of Continuous Glucose Monitoring (CGM) Industry

The continuous glucose monitoring market is consolidated and consists of a few major players. Some companies currently dominating the market are Dexcom, Abbott, and Medtronic. A major share of the market is held by CGM manufacturers that are concurrent with strategy-based M&A operations. They are constantly entering new markets to generate new revenue streams and boost existing ones. These measures taken by the market players will ensure a competitive marketplace, forcing the companies to experiment with newer technologies to ensure uniqueness in their products. One of the implications of the competition in the market is that it will ensure a constant decrease in the average selling price of the CGM units produced. Companies are collaborating to increase their technological know-how and to fasten the product development cycle.

Continuous Glucose Monitoring (CGM) Market Leaders

  1. Medtronic Plc

  2. Dexcom, Inc.

  3. Abbott Laboratories

  4. Senseonics Holdings, Inc.

  5. Roche

*Disclaimer: Major Players sorted in no particular order

Continuous Glucose Monitoring (CGM) Market Concentration

CGM Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)